BiomX Inc. 8-K

What Happened
BiomX, Inc. (ticker: PHGE) filed an 8‑K on March 27, 2026 reporting that on March 25, 2026 it received a written notice from the NYSE American that the company is not in compliance with the exchange’s continued listing standards related to stockholders’ equity. The notice requires BiomX to submit a plan by April 24, 2026 describing how it will regain compliance by September 25, 2027. The company issued a press release on March 27, 2026 discussing the notice and says management is reviewing options and expects to file the required plan.

Key Details

• NYSE American cited non‑compliance with Section 1003(a)(i), (ii) and (iii) of the Company Guide, which set stockholders’ equity thresholds of $2.0M, $4.0M and $6.0M depending on prior years of losses.
• BiomX is not currently eligible for listed exemptions (for example, the market cap exemption for companies with total market value over $50M).
• Deadline to submit a compliance plan: April 24, 2026. Deadline to regain compliance per an accepted plan: September 25, 2027.
• The notice does not have an immediate effect on listing or trading; PHGE will continue to trade on NYSE American while the company submits and (if accepted) implements a plan. Delisting proceedings could begin if no plan is submitted, a plan is rejected, or the company fails to make required progress; appeal rights are available under the exchange rules.

Why It Matters
This notice signals a material listing risk: if BiomX cannot show a credible plan and regain the required equity levels, the NYSE American could begin delisting proceedings. For investors, the immediate impact is limited—shares continue to trade—but the risk of future delisting can reduce liquidity and may affect share value. Management’s upcoming compliance plan (due April 24, 2026) and any concrete steps to improve equity or meet listing standards will be the key developments to watch.